AVEO Oncology, an LG Chem company, was looking to deliver synchronized, omnichannel communications to engage healthcare providers (HCPs) with FOTIVDA ®️ (tivozanib) brand experiences. The team recognized that moving beyond a traditional multichannel approach towards omnichannel would unlock more meaningful brand experiences and a competitive advantage.
To achieve this, AVEO partnered with Lumanity, a leading global life sciences strategy services company, and leveraged its ONEE™️ platform (Omnichannel Network Engagement Experience™️). Built from the ground up with flexibility in mind, the proprietary omnichannel engine was able to leverage existing AVEO MarTech and unify disparate data, content, technology, and analytics to deliver consistent, coordinated customer experiences across multiple channels.
The Lumanity team needed seamless access to NPI-level engagement data that was both integrated into their ONEE customer data platform (CDP), and automated, to reduce lag time, enable faster personalization, and ensure synchronization across channels. For this, AVEO and Lumanity turned to PulsePoint.
The coordinated approach drove timely engagement at scale, resulting in new HCP meetings, new scripts, and tangible channel-level gains.
Access the full case study to see the full solution and results →
